DanCann Pharma A/S: The Board of Directors has resolved on directed share issues of DKK 4.5 million and proposal of directed share issues of DKK 0.4 million
COPENHAGEN, Denmark, 25 November 2024 – The Board of Directors of DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, has today decided to carry out directed issues of shares and warrants to investors pursuant to an authorisation granted by the general meeting, cf. clause 6.4 of the articles of association. The investors have subscribed for all shares and warrants in the directed issues. Through the directed issues of shares and warrants, the Company will initially receive approximately DKK 4.5 million before deduction of transaction